News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Dup 15q Alliance
MDedge Endocrinology
Ehlers-Danlos Society
MDedge Endocrinology
International Pemphigus and Pemphigoid Foundation
MDedge Endocrinology
MDS Foundation
MDedge Endocrinology
Morgan Leary Vaughan Foundation
MDedge Endocrinology
FDA advisory committee recommends volanesorsen for rare triglyceride disorder
MDedge Endocrinology
Osteogenesis Imperfecta Foundation (OIF)
MDedge Endocrinology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Endocrinology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Endocrinology
RFPs Available for the Study of Three Rare Diseases
MDedge Endocrinology